Recent advance of erythrocyte-mimicking nanovehicles: From bench to bedside

J Control Release. 2019 Nov 28:314:81-91. doi: 10.1016/j.jconrel.2019.10.032. Epub 2019 Oct 20.

Abstract

Erythrocyte-mimicking nanovehicles (EM-NVs) are developed by fusing nanoparticle cores with naturally derived erythrocyte membranes. Compared with conventional nanosystems, EM-NVs hold preferable characteristics of prolonged blood circulation time and immune evasion. Due to the cell surface mimetic properties, along with tailored core material, EM-NVs have huge application potential in a large variety of biomedical fields, which are anticipated to revolutionize the present theranostic modalities of diseases in clinic. This review focuses on (I) drug carriers, (II) photosensitizers, (III) antidotes, (IV) vaccines and (V) probes, aiming to present an overall summary of the latest advancement in the application of EM-NVs, and highlight the major challenges and opportunities in this field.

Keywords: Biomedical application; Biomimetic; Erythrocyte; Nanovehicles.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomimetic Materials / chemistry*
  • Drug Carriers / chemistry
  • Erythrocyte Membrane / chemistry
  • Erythrocytes / chemistry*
  • Humans
  • Nanoparticles*
  • Surface Properties
  • Theranostic Nanomedicine / methods

Substances

  • Drug Carriers